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Philadelphia. Pennsylvania
Vasodilators have been found effective in increasing blood
flow in the lateral border surrounding a central zone of
infarction, but any change in blood flow to this border
zone may be to the normal tissue in this zone, rather
than to the ischemic tissue. In this study of the effects
of nifedipine on collateral blood flow, 31 open chest dogs
underwent coronary occlusion followed by nifedipine in-
fusion, either 3 or I J-tg/kg per min. A balloon perfusion
microsphere labeling device was used to separate the
Because the extent of myocardial infarction is determined
primarily by myocardial blood flow (1,2) , there has been
considerable interest in using pharmacologic means to en-
hance flow to ischemic myocardium to limit infarct size (3) .
The influence of vasodilators on blood flow to ischemic
myocardium is controversial. As pointed out by Patterson
and Kirk (4), dipyridamole has been reported to decrease
(5,6) , not affect (7) or increase (8) collateral flow to isch-
emic myocardium. In addition, agents that do not affect
central ischemic zone flow may increase blood flow to the
border zone between nonischemic and ischemic regions (4) .
Nifedipine is a potent vasodilator (9) that has been pro-
posed as an agent to limit myocardial infarct size (10, II).
In the study by Henry et al. (10), nifedipine increased blood
flow primarily to marginally ischemic tissue. However, its
relative effects on blood flow to ischemic tissue and non-
ischemic admixed with ischemic tissue in the lateral border
zone are unknown . Thus, we studied the effect of nifedipine
on the blood supply to the central ischemic. intermediate
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influence of normally perfused tissue overlapping with
ischemic tissue in the lateral border zone. Nifedipine
increased blood flowin the border lone, but this increase
could be accounted for by the effect of nifedipine on
admixed normal tissue. In the central ischemic zone,
nifedipine administration resulted in a decrease in col-
lateral blood flow. Thus, to fully understand the effect
of a vasodilator on ischemic zone blood flow, it is nec-
essary to account for flow in overlapping normal tissue.
ischemic and border ischemic myocardium in 31 open chest
dogs . To better understand the effects of nifedipine, we
used a technique that separately evaluated its effects on
ischemic tissue in a mixed tissue sample (12,13).
Methods
Experimental preparation. The 31 dogs were prepared
as described previously (14) . Briefly , they were anesthetized
with pentobartital and placed on a respirator. Catheters were
passed into the thoracic aorta for arterial pressure monitoring
and into the abdominal aorta for blood withdrawal. A tho-
racotomy was performed; catheters were passed into the
left atrial appendage for micro sphere injection , and into the
left ventricle for recording of pressure .
The left anterior descending coronary artery was can-
nulated and perfused from the left common carotid artery
through plastic tubing . Great care was taken to avoid oc-
cluding any visible branch vessels. Perfusion pressure in
the cannulation system just proximal to the insertion point
of the cannula in the coron ary artery was monitored with a
strain gauge (Statham P23 Db) and coronary flow was mon-
itored with an electromagnetic flow probe (Micron Instru-
ments) . Two side arms of the cannula system contained a
balloon perfusion system that will be described later. During
cannula perfusion of the left anterior descending artery in
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seven additionaldogs, pressure at the tip of the cannula was
measured with an 18 or 21 gauge needle passed into the
artery distal to the cannula. In four of these dogs pressure
in the circumflex artery was also measured with an 18gauge
needle. The needles were attached to Statham P23 Db strain
gauges. No gradient could be measured between cannula
tip pressure, pressure in the cannula system proximal to the
needle and aortic pressure and, in four dogs, circumflex
pressure at maximal systole and minimal diastole. Phase lag
was a small fraction of the cardiac cycle, and at no time
during the cardiac cycle did any of these pressures differ
by more than 5 mm Hg. In addition, the cannula system
was checked for stenosis in vitro using warm blood via a
Harvard pump. Pressure was monitored in the proximal
cannula system and at the tip, and no gradient was noted
at flows of up to 46 mllmin. Diastolic perfusion pressure in
the tubing was identical to aortic pressure at flows up to
100 mllmin in all dogs before occlusion.
The presence of coronary vascular reserve was deter-
mined using a 10 second period of total occlusion followed
by reperfusion. The 31 dogs in this study all had greater
than 100% reactive hyperemia with peak flow during re-
active hyperemia averaging 2.5 ± 0.4 times control period
flow.
Ischemic tissue labeling technique. The two side arms
of the cannula system were connected to a two chamber
balloonperfusion system (12,13). The system is constructed
of a 50 011 syringe barrel and a cork with two holes con-
taining plastic cannulas 4 0101 in internal diameter. The
plasticcannulas connectoutside the syringe to two side arms
of the cannulation system. On the inside of the syringe, the
proximal plastic cannula connected to a large compliant
balloon, while the other cannula opened into the syringe.
A stopcock was placed at the top of the syringe. Initially
the side arms of the cannulation system were clamped off
so that the path of the blood was directly from the carotid
artery through the cannulation system to the left anterior
descending coronary artery. By adjusting the clamps on the
reservoir system and the stopcock at the top of the reservoir,
the outer chamber was filled with blood. The stopcock was
then closed and the clamps adjusted so that the outer cham-
ber of the reservoir perfused the left anterior descending
artery at systemic blood pressure, while the blood from the
carotid artery was trapped in the balloon. During this period
of independent perfusion of the left anterior descending
artery, a set of microspheres was injected into the left atrium.
Thus, the left anterior descending artery was perfused from
the outer chamber at systemic pressure with blood contain-
ing no microspheres, while microspheres destined for the
left anterior descending artery were trapped in the inner
chamber of the reservoir. Thus, myocardium in the zone
subserved by the cannula system was labeled by the absence
of microspheres.
Thefraction ofnormal zone tissue (FNZT) interdigitating
with ischemic tissue in any tissue sample was calculated by:
FNZT = MBF1Z
MBFNZ '
where MBF1Z is the blood flow in ml/g per min in the tissue
sample and MBFNZ is the blood flow in mllg per min in the
remote normal zone. It was possible to make this deter-
mination because collateral flow to the subserved zone was
minimal while the left anterior descending artery was per-
fused at systemic pressure. In addition, perfusion through
the cannula system was continued for I full minute after
the microsphere injection and flush were completed (a total
of 80 to 90 seconds of balloon perfusion). All dogs with a
decrease in perfusion pressure in the cannula system during
this period were excluded from further study. The balloon
was checked for leaks before every experiment. By strict
adherence to this protocol adequate exclusion of micros-
pheres from the subserved zone was assured.
Subsequent ischemic tissue blood flow was correctedfor
overlapping normal zone tissue by the equation:
MBF. = MBFT - MBFN Z ' FNZT
IZ I - FNZT '
whereFNZT is the fractionof normal zone tissue in a mixed
sample, MBFNZ is the normal zone flow, MBFT is the un-
corrected blood flow to a mixed sample and MBF1Z is the
blood flow to the ischemic tissue in a mixed tissue sample.
II' there was a gradient in perfusion pressure between
normaltissue and tissue subservedby the cannulationsystem
during the balloon perfusion period, microspheres could
pass into the subserved zone by way of the collateral cir-
culation. We do not think that this is a major problem for
several reasons. Any perfusion gradient would be small, as
noted before. Furthermore, the presence of coronary vas-
cular reserve with a reactive hyperemic response 2.5 times
the control level and the lack of a decrease in coronary flow
during balloon perfusion suggest that the subserved vas-
culature autoregulated to a level of flow similar to that in
the normal zone. Because collateral flow is a small fraction
of normal flow, collateral vessels have a relatively high
resistance, and a small decrease in pressure should allow
few microspheres to pass through.
Experimental protocol. After the preparation was com-
plete and the left anterior descending artery cannulated, the
dog's condition was allowed to stabilize for 15 minutes. A
first set of microspheres was then injected during indepen-
dent left anterior descending artery perfusion of micro-
sphere-free blood to label the ischemic tissue. The left an-
terior descending artery was then occluded to render the
subserved zone ischemic. Ten minutes after occlusion a
second set of microspheres was given. Intravenous nifedi-
pine (3 j.Lg/kg per min in 21 dogs and I j.Lg/kg per min in
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10 dogs) was then given for 15 minutes and followed by
injection of a third set of microspheres.
Tissue preparation. Just before sacrifice, Evans blue
dye was injected by hand in the coronary cannula with
sufficient force to roughly stain the ischemic region. A 1.5
em wide ring of myocardium was cut with the path of the
cut perpendicular to the blue line separating normal (pink)
from ischemic (blue) tissue. A 1 cm transmural section of
myocardium was taken from the remote normal part of the
ring. The ring was then cut with care at the blue line to
keep most of the blue-stained tissue on the ischemic side.
A 5 mm transmural sample was taken on the normal (pink)
side followed by two sequential transmural 5 mm samples
of myocardium taken on the ischemic (blue) side; these were
labeled border ischemic and intermediate ischemic. Then a
1 em central ischemic sample was taken. The sectionsfrom
border normal to central ischemic were adjacent in the ap-
propriate sequence, and no tissue between these samples
was discarded. All samples were divided into subendocar-
dial, mid-myocardial and subepicardial thirds. Blood flow
was then determined for each layer and transmurally.
The tissue samples were each weighed and counted in a
Beckman 8000 well gamma-counter for 10 minutes. Myo-
cardial blood flow was determined by the method of Hey-
mann et al. (15).
Data analysis. All data are expressed as mean ± stan-
dard deviation. Differences were analyzed for significance
by a two-way analysis of variance with randomized block
design (16).
Results
Hemodynamics. Data for each hemodynamic variable
for the 21 dogs receiving 3 jLg/kg per min and the 10 dogs
receiving 1 jLg/kg per min nifedipine are presented in Table
I. Heart rate was unchanged throughout the experiment in
both groups. During the balloon perfusion period, neither
aortic pressure nor perfusionpressure changed from control
values. Perfusion systolic and diastolic pressures were not
significantly different from aortic pressure during either the
controlor balloonperiods. Aorticsystolicanddiastolicpres-
sures in the group receiving 3 jLg/kg per min decreased
slightly after coronary occlusion. After nifedipine infusion
aortic systolic and diastolic pressures decreased at bothdoses,
although the decrease in systolic pressure in the group given
I jLg/kg per min was not significant (NS). Left ventricular
end-diastolic pressure was unchanged during balloon per-
fusion, but increased slightly after occlusion in the 3 jLg/kg
per min group. Nifedipine infusion did not affect left ven-
tricularend-diastolic pressure. Coronaryflow measuredwith
Table 1. Hemodynamic Data on 21 Dogs Receiving 3 ~g/kg per min Nifedipine and 10 Dogs Receiving
1 ~g/kg per min Nifedipine*
Coronary
Occlusion Nifedipine
136 ± 23 132 ± 22
116 ± 20 117 ± 22
106 ± 10* 100 ± 12t
104 ± 9 98 ± 10
80 ± 10* 68 ± 14t
82 ± 10 71 ± l4t
Balloon
Control Perfusion
Heart rate (beats/min)
3 iLg/kg per min 133 ± 20 135 ± 20
1 iLg/kg per min 118 ± 16 116 ± 17
Aortic pressure (mm Hg)
Systolic
3 iLg/kg per min 113 ± I I 112 ± 9
I iLg/kg per min 108 ± 6 107 ± 9
Diastolic
3 iLg/kg per min 87 ± I I 85 ± 10
I iLg/kg per min 82 ± 8 81 ± 10
Perfusion pressure (mm Hg)
Systolic
3 iLg/kg per min 112 ± 10 110 ± 8
I iLg/kg per min 107 ± 7 105 ± 8
Diastolic
3 iLg/kg per min 85 ± 10 84 ± 10
I iLg/kg per min 82 ± 8 81 ± II
LVEDP (mm Hg)
3 iLg/kg per min 8 ± 4 8 ± 3
I iLg/kg per min 6 ± 4 6 ± 4
Coronary flow (ml/min)
3 iLg/kg per min 27 ± 8 28 ± 9
1 iLg/kg per min 21 ± 9 21 ± 8
10 ± 4*
8 ± 3
10 ± 4*
8 ± 3
*p < 0.05 compared with control; tp < 0.001 compared with coronary occlusion. LVEDP = left ventricular end-diastolic pressure.
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an in-line electromagnetic flow probe in the cannulation
system was was unchanged from control to balloon perfusion.
Effect of nifedipine on myocardial blood flow. The
effect of 3 p,g/kg per min nifedipine on transmural flow and
myocardial blood flow by layer in 21 dogs is presented in
Table 2. Nifedipine increased blood flow in the mid-myo-
cardium and subepicardium and transmurally in the normal
and border normal zones. In the border ischemic zone, ni-
fedipine increased subepicardial and transmural blood flow,
but after subtraction of overlapping normal zone tissue,
nifedipine did not affect blood flow to this zone. Nifedipine
did not affect uncorrected blood flow in the intermediate
and central ischemic zones, but after subtraction of over-
lapping normal zone tissue, nifedipine resulted in a decrease
in subepicardial and transmural blood flow in these zones.
Effect of nifedipine on dogs with greatest re-
sponse. As the increase in normal zone blood flow was
modest, we examined transmural flow in 9 of the 21 dogs
receiving 3 p,g/kg per min nifedipine with the largest in-
creases in normal zone blood flow. Normal zone blood flow
was 1.41 ± 0.31 ml/g per min before and 2.22 ± 0.37
ml/g per min after nifedipine infusion (probability [pI <
0.0001). Border ischemic flow increased from 0.5 I ± 0.31
to 0.67 ± 0.48 mllg per min (p = 0.035). Central ischemic
zone flow was 0.12 ± 0.05 before and 0.10 ± 0.06 after
nifedipine (difference not signifi cant INS]). Aftercorrection
for overlapping normal tissue, border ischemic flow was
0.35 ± 0.22 mllg per min before and 0.34 ± 0.19 ml/g
per min after nifedipine (NS), while in the central ischemic
zone, flow decreased from 0.10 ± 0.04 to 0.07 ± 0.05
ml/g per min after nifedipine (p = 0.014). Thus, in the
subgroup with the largest nifedipine effect, the results were
all similar to those in the total group receiving 3 p,g/kg per
min of nifedipine.
Effect of nifedipine according to fraction of normal
zone tissue. Tissue samples in the 3 p,g/kg per min group
from the central, intermediate and border ischemic zones
were grouped accordingto the fraction of normal zone tissue
in each sample, and the infl uence of nifedipine on blood
flow in each group was examined (Fig. I). In the samples
with a fraction of normal zone tissue greater than 0.25,
blood flow increased from 1.26 ± 0.62 to 1.41 ± 0.57
rnl/g per min after nifedipine infusion. In the samples with
a fraction of normal zone of tissue of 0.05 to 0.25, blood
Table 2. Influence of 3 j.tg/kg per min Nifedipine on Myocardial Blood Flow (mllg per min)
Uncorrec ted
Pre-Nil' Post-Nil'
NZ
Subendo 1.61 ± 0 .52 I. 72 ± 0 .63
Mid-rnyo 1.53 ± 0 .53 1.92 ± 0.7 1i'
Subepi 1.46 ± 0 .50 2.09 ± 0 .73'1'
Trans 1.52 ± 0.49 I. 91 ± O.58·r
BNZ
Sube ndo 1.40 :!: 0.62 1.44 :!: O.n5
Mid-myo 1.44 :!: 0.58 1.66 :!: 0.n5 *
Subepi 1.63 :!: 0 .59 2.1 1 :!: 85 ~:
Trans 1.49 :!: 0 .57 1.73 :!: 0 .63i'
BIZ
Subendo 0.55 :!: 0 .69 0.55 :!: O.ns
Mid-myo 0 .65 ± 0 .70 0.82 :!: O.X2
Sube pi 1.03 :!: 0.56 1.2 1 :!: 0.80*
Trans 0.76 :!: 0 .6 1 0 .84 :!: O.6M
liZ
Subendo 0. 16 :!: 0.3 1 0.15 :!: (U2
Mid-myo 0.2 1 :!: 0.35 0 .28 ± O,4n
Subepi 0.53 ± 0.5 1 0 .52 :!: 0.54
Trans 0 .3 1 ± 0 .38 0 .30 :!: 0.39
CIZ
Subendo 0.08 :!: 0 . 10 0 .12 :!: 0 .23
Mid-rnyo 0. 12 :!: 0. 11 0.11 :!: n.11
Subepi 0.39 ± 0 .30 0 .34 :!: 0 .28*
Trans 0.19 ± 0 . 15 0 .l g ± 0 . 14
Pre-N il'
0 . 18 :!: 0 .20
0.4 1 :!: 0 .52
0.65 :!: 0 .59
0 .63 :!: 0 .n3
0.05 :!: 0.n8
0. 12 ± 0 . 115
0 .49 ± 0 .55
0 .23 ± 0 .22
(1.04 ± 0 .08
o.os ± 0 . 12
(U5 :!: 0.3 1
n .17 ± 0 . 15
Corrected
Post-Nil'
0 .25 :!: 0 .38
0.45 :!: 0,48
0 .54 :!: 0.44
0.52 :!: 0 .38
0.05 ± 0 .08
0 . 11 ± 0.15
0.40 ± 052*
0. 19 ± 0.22 *
n.03 ± 0 .07
0.07 ± 0. 12
n.29 ± 0.29 t
0.14 ± 0.14 *
*p < 0.05 compared with value to left; t p < 0.0 1 compared with value to left: t p < (1.001 compared with value to left. BIZ = border ischemic
zone; BNZ = border normal zone ; CIZ = central ischemic zone ; lIZ = intermed iate ischemic zone; Mid-rnyo = mid-myocardium; Nil' = nifcdipin c:
NZ = normal zone; Subendo = subendocardium; Subepi = subepi card ium: Trans = transmural.
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flow was 0.33 ± 0.35 before and unchanged at 0.35 ±
0.24 ml/g per min after nifedipine. In contrast, in samples
with a fraction of normal zone tissue of less than 0.05,
blood flow decreased after nifedipine from 0.22 ± 0.14 to
0.19 to 0.13 ml/g per min. Thus, even without correcting
for overlapping normal tissue, in samples consisting largely
of ischemic tissue, nifedipine infusion resulted in a decrease
in myocardial blood flow .
Effect of nifedipine, 1 #Lg/kg per min, on myocardial
blood flow (Table 3). Nifedipine caused a slight increase
in blood flow in the normal and border normal subepicar-
dium. Transmural flow was raised only in the normal zone.
Border ischemic subepicardial flow was increased slightly
after nifedipine infusion, but this could be accounted for
entirely by overlapping normal zone tissue. Nifedipine had
no signifi cant effect in the ischemic zone, although the trend
was toward a decrease after accounting for overlap.
>0.25 0.05 to 0.25 <0.05
FNZT
Figure 1. Effect of nifedipine on blood flow to mixed tissue sam-
ples in the ischemic zone. Samples were grouped according to the
fraction of normalzone tissue in each sample. Samples with greater
than 25% nonischemic tissue on the left. 5 to 25% in the middle
and less than 5% on the right. In each group blood flow before
nifedipine is on the left and fl ow after nifedipine on the right.
FNZT = fraction of normal zone tissue; MBF = myocardial blood
flow.
Discussion
When interpreting these data it is important to understand
what we mean by the ischemic zone and ischemic tissue.
The ischemic zone is the region of the left ventricle sub-
served by the occluded coronary artery. Because of overlap
of myocardium supplied by vessels other than that which is
occluded, there is nonischemic tissue in the ischemic zone
Table 3. Effect of I /Lg/kg per min Nifedipine on Myocardial Blood Flow (mllg per min)
Uncorrected
Pre-Nil' Post-Nil'
NZ
Subend o 1.07 ::!: 0.32 1.11 ::!: 0.38
Mid-myo 1.03 ::!: 0.32 1.15 ::!: 0.Q35
Subcp i 1.05 ::!: 0 .38 1.36 ::!: 0.47 *
Trans 1.05 ::!: 0 .31 1.23 ::!: 0.40 *
BNZ
Subcndo 1.04 ::!: 0 .32 1.09 ::!: 0.41
Mid-myo 1.08 ::!: 0.38 1.18 ::!: 0.47
Subcpi 1.19 ::!: 0.5\ 1.43 ::!: 0 .5 1*
Trans 1.11 ::!: 0.40 1.22 ::!: 0.40
BIZ
Subcndo 0 .54 :!: 0 .32 0.57 ::!: 0.28
Mid-myo 0.60 ::!: 0.4 1 0.68 ::!: 0.47
Subcpi 0 .86 ::!: 0.5 1 1.02 ::!: 0.66*
Trans 0 .70 ::!: 0.39 0.75 ::!: 0 .52
liZ
Subcndo 0.30 ::!: 0.4 1 0.30 ::!: 0 .35
Mid-myo 0.28 ::!: 0 .35 0.30 ::!: 0 .38
Subcpi 0.5 1 ± 0.54 0.50 ± 0 .54
Trans 0 .38 ::!: 0 .43 0.42 ± 0.49
e lZ
Subcndo 0 . 19 ::!: 0.28 0.20 ± 0.28
Mid-rnyo 0. 15 ::!: 0.19 0. 16 ± 0 . 19
Subcpi 0.40 ::!: 0 .38 0.38 ± 0.32
Trans 0.2 8 ± 0 .26 0.28 ± 0 .25
*p < 0.05 compared with value to left. Abbreviations as in Table 2.
Pre-Nil'
0.26 ::!: 0.22
0 .38 ± 0.44
0 .55 ::!: 0.44
0.46 ::!: 0 .39
0 .22 :!: 0.4 1
0 .17 :!: 0 .22
0 .38 :!: 0.4 1
0.27 ::!: 0.3f>
0. 12 ::!: 0 .22
0 .09 ± 0 .11
0.32 ± 0.32
0.\9 ± 0 .23
Corrected
Post-Nil'
0 .29 ::!: 0 .22
0 .46 ::!: 0 .47
0 .52 ::!: 0 .5 1
0.4 9 ::!: 0.48
0 .2 1 ::!: 0 .38
0 . 18 ::!: 0 .22
0 .24 ± 0 .28
0 . 19 ± 0 .23
0 .10 ::!: 0 . 16
0 .10 ::!: 0 .16
0.24 ± 0. 22
0.16 ::!: 0 .20
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(17,18). Thus, by ischemic tissue we mean myocardium
supplied by the occluded coronary vessel. The balloon per-
fusion technique allows separate evaluation of ischemic and
nonischemic tissue in the ischemic zone (12,13).
Effect of nifedipine on collateral blood flow. After
administration of 3 p,g/kg per min nifedipine intravenously,
normal zone and border normal blood flow increased sig-
nificantly. Border ischemic zone blood flow also increased
significantly. Intermediate ischemic and central ischemic
tissues were unchanged. After correction for overlapping
normal zone tissue, however, border ischemic flow was
unchanged by nifedipine, and intermediate and central isch-
emic flow actually declined. In addition, study of samples
of ischemic tissue with negligible normal zone contribution
revealed that blood flow decreased after nifedipine infusion
even without correction for overlap. We observed only a
minor increase in blood flow to the normal zone with I
p,g/kg per min of nifedipine. In the central ischemic zone,
blood flow did not change significantly, although it tended
to decrease. Thus, neither dose of nifedipine caused col-
lateral flow to increase. In addition, in the dogs with the
greatest response to nifedipine in the normal zone, central
ischemic blood flow decreased after nifedipine infusion.
The effects of nifedipine were largely confined to the
subepicardium. Thus, nifedipine largely increased normal
zone blood flow in vessels with the largest remaining au-
toregulatory reserve. These observations suggest that the
most likely explanation for the divergent effects of nifedi-
pine on ischemic and normal tissues is that because nife-
dipine causes vasodilation, the resistance vessels in the nor-
mal zone, with preserved coronary vascular reserve, dilate
and thus normalzone flow increases. However. in the central
ischemic zone the resistance vessels are already fully vaso-
dilated and there is no reserve; thus, when perfusion pres-
sure decreases after nifedipine infusion, collateral flow de-
creases, The decrease in blood flow after nifedipine in this
model was confined to the ischemic subepicardium. Blood
flow to the ischemic subendocardium was sufficiently low
so that any change in flow would be difficult to measure.
After nifedipine infusion at 3 p,g/kg per min, systemic blood
pressure was 100/68 mm Hg. This is not a sufficientdegree
of hypotension to exhaust coronary vascular reserve (10).
Thus. even mildly hypotensive doses of nifedipine may
decrease collateral blood flow.
Comparison with previous studies. This study is su-
perficially at variance with the study of Henry et al. (10)
because it shows an increase in collateral flow after nife-
dipine infusion. However, the increase in collateral flow
was greatest in the marginally ischemic and least in the
severely ischemic tissue. The effect of overlapping normal
zone tissue was not studied, and there are also technical
differences in that nifedipine was infused for I day. and
groups were compared receiving and not receiving nifedi-
pine. Thus. each sample could serve as its own control.
Henry et al. suggested that nifedipine leads to a reduction
in infarct size, which is consistent with previous work from
our laboratory showing that nifedipine may preserve myo-
cardial contraction (19,20). This protective effect may be
mediated. as suggested by Henry et al. (19), by preventing
accumulation of intracellular calcium, rather than by in-
creased collateral flow. However, recent data (21), in a
reperfusion model in the baboon have cast doubt on whether
nifedipine does reduce infarct size.
We thank Scott Clulcy. Janice Phillips and Robert Krumm for Iheir expert
technical assistance.
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